Boralex Inc. enters the final stretch before its May 13 earnings report with a distinctive tension: a confirmed C$9.7 billion acquisition by Brookfield and La Caisse de dépôt et placement du Québec on one hand, and a sharp acceleration in short interest on the other.
Short sellers have rebuilt positions aggressively since late April. Short interest as a percentage of free float has climbed to roughly 4.0%, up nearly 20% on the week — the largest single-week jump in the 30-day window on record here. The move is concentrated: shares short were steady around 3.3–3.5 million through most of April, then jumped decisively through April 20–21 and have climbed each session since. The pattern is consistent with spread-trade positioning around the announced deal — shorts selling BLX against Brookfield to capture the spread between the current trading price and the announced takeout terms, rather than a directional bear thesis on the company's operations.
The lending market supports that read: borrow conditions are easy. Availability is wide — far more than enough supply relative to short demand — and cost to borrow has retreated sharply from its April 20 peak near 2.7%, settling back to 1.3% by April 28 after a 36% weekly decline. The 52-week availability peak of 26.1% utilization (versus the current 5.8%) confirms this is a stock with a historically thin short base. Nothing in the borrow market suggests a squeeze is developing; if anything, the fresh short inventory is flowing in smoothly because lendable supply is plentiful.
The institutional ownership picture reinforces the deal-driven dynamic. La Caisse de dépôt — one of the two acquirers — already holds 15.3% of shares outstanding and has not changed that position since March. Vanguard and BlackRock each trimmed or barely moved their stakes at the margin. The top ten holders collectively control well over 40% of shares, giving the deal a stable base. Q1 earnings on May 13 land well inside the acquisition timeline, making them more of a compliance disclosure than a market-moving event; the last two prints caused barely any price reaction, with the February 2026 release moving the stock less than 1% on day one.
The Street has little reason to reprice dramatically at current levels. The mean analyst target sits at C$36.43, essentially in line with the April 28 close of C$36.73 — a spread of less than 1% — which is consistent with the stock trading to deal value rather than on underlying fundamentals. The forward P/E of 39.5x has expanded about 30% over the past month, again reflecting deal pricing rather than an organic re-rating. Factor scores are mixed: the 12-month forward EPS estimate trend ranks in the 95th percentile, a genuinely strong reading, while EPS surprise and momentum scores are weak, sitting in the mid-single digits. EV/EBITDA of 11.2x is compressed relative to what would normally be a growth renewable business, broadly reflecting the announced takeout multiple.
Among correlated peers, Northland Power gained 8.1% on the week while Brookfield Renewable Partners added 2.7%, both outperforming BLX's flat weekly showing of -0.05%. The relative underperformance is consistent with a stock already priced to an announced deal rather than one still moving on sector momentum. A fresh indigenous framework agreement with the W8banaki Nation signed April 24 underlines that Boralex's development pipeline remains active, but operational news will carry limited weight until the acquisition closes. The next date worth watching is the May 13 earnings call — less for the numbers themselves and more for any management commentary on transaction timing and regulatory progress.
See the live data behind this article on ORTEX.
Open BLX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
